Entity Common Stock, Shares Outstanding of Protalix BioTherapeutics, Inc. from 01 Aug 2011 to 01 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Protalix BioTherapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2011 to 01 Nov 2025.
  • Protalix BioTherapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 01 Nov 2025 was 80,421,181, a 9.2% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Protalix BioTherapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 80,421,181 +6,787,598 +9.2% 01 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 79,732,115 +6,189,441 +8.4% 01 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 78,032,585 +4,980,461 +6.8% 14 Mar 2025 10-K 17 Mar 2025 2024 FY
Q3 2024 73,633,583 +681,459 +0.93% 01 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 73,542,674 +1,961,912 +2.7% 01 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 73,052,124 +7,637,207 +12% 01 Mar 2024 10-K 14 Mar 2024 2023 FY
Q3 2023 72,952,124 +22,286,526 +44% 01 Nov 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 71,580,762 +21,827,353 +44% 01 Aug 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 65,414,917 +19,098,788 +41% 30 Apr 2023 10-Q 04 May 2023 2023 Q1
Q3 2022 50,665,598 +5,108,951 +11% 10 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 49,753,409 +4,196,762 +9.2% 12 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 46,316,129 +933,298 +2.1% 15 Mar 2022 10-K 31 Mar 2022 2021 FY
Q3 2021 45,556,647 +12,219,938 +37% 01 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 45,556,647 +13,114,011 +40% 01 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 45,382,831 +30,544,618 +206% 28 Apr 2021 10-K/A 30 Apr 2021 2020 FY
Q3 2020 33,336,709 -115,045,590 -78% 15 Oct 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 32,442,636 -115,939,663 -78% 01 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 14,838,213 -133,544,086 -90% 01 Mar 2020 10-K 12 Mar 2020 2019 FY
Q3 2019 148,382,299 +7,378 +0.01% 01 Nov 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 148,382,299 +198,708 +0.13% 01 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 148,382,299 +2,812,344 +1.9% 01 Mar 2019 10-K 18 Mar 2019 2018 FY
Q3 2018 148,374,921 +8,647,248 +6.2% 01 Nov 2018 10-Q 18 Mar 2019 2018 Q3
Q2 2018 148,183,591 +14,828,552 +11% 01 Aug 2018 10-Q 18 Mar 2019 2018 Q2
Q1 2018 145,569,955 +21,435,870 +17% 01 Mar 2018 10-K 06 Mar 2018 2017 FY
Q3 2017 139,727,673 +39,797,271 +40% 01 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 133,355,039 +33,546,799 +34% 01 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 124,134,085 +24,325,847 +24% 01 Mar 2017 10-K 16 Mar 2017 2016 FY
Q3 2016 99,930,402 +130,005 +0.13% 01 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 99,808,240 +5,656,922 +6% 01 Aug 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 99,808,238 +6,204,419 +6.6% 01 Mar 2016 10-K 08 Mar 2016 2015 FY
Q3 2015 99,800,397 +6,127,833 +6.5% 01 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 94,151,318 +486,420 +0.52% 01 Aug 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 93,603,819 +23,355 +0.02% 01 Mar 2015 10-K 12 Mar 2015 2014 FY
Q3 2014 93,672,564 +110,799 +0.12% 01 Nov 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 93,664,898 +127,538 +0.14% 01 Aug 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 93,580,464 +77,196 +0.08% 01 Mar 2014 10-K 13 Mar 2014 2013 FY
Q3 2013 93,561,765 +96,596 +0.1% 01 Nov 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 93,537,360 +1,613,954 +1.8% 01 Aug 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 93,503,268 +1,611,690 +1.8% 01 May 2013 10-Q 09 May 2013 2013 Q1
Q3 2012 93,465,169 +7,841,542 +9.2% 04 Nov 2012 10-Q 07 Nov 2012 2012 Q3
Q2 2012 91,923,406 +6,339,096 +7.4% 30 Jul 2012 10-Q 03 Aug 2012 2012 Q2
Q1 2012 91,891,578 03 May 2012 10-Q 09 May 2012 2012 Q1
Q3 2011 85,623,627 01 Nov 2011 10-Q 07 Nov 2011 2011 Q3
Q2 2011 85,584,310 01 Aug 2011 10-Q 08 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.